Literature DB >> 2682524

Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity.

K Mori1, C Boiziau, C Cazenave, M Matsukura, C Subasinghe, J S Cohen, S Broder, J J Toulmé, C A Stein.   

Abstract

Oligodeoxynucleotides with a phosphorus atom in which one of the non-bridging oxygen atoms is substituted by selenium were prepared and investigated with respect to their antisense properties. A general synthesis of phosphoroselenoate analogs of oligonucleotides is described using potassium selenocyanate as the selenium donor. The compounds, characterized by 31P NMR, were shown to decompose to phosphate with a half-life of ca. 30 days. Melting temperatures of duplexes between poly(rA) or poly(rI) with oligo(dT) and oligo(dC), respectively, indicate diminished hybridization capability of phosphoroselenoate oligomers relative to both the unmodified phosphodiester oligomers and the phosphorothioate congeners. A phosphoroselenoate 17-mer is a sequence specific inhibitor of rabbit beta-globin synthesis in wheat germ extract and in injected Xenopus oocytes. In contrast phosphoroselenoate analogs are potent non-sequence specific inhibitors in rabbit reticulocyte lysate. In vitro HIV assays were carried out on a phosphoroselenoate sequence and compared with a phosphorothioate analogue that has previously been shown to exhibit anti-HIV activity (Matsukura et al., Proc. Natl. Acad. Sci. (1987) 84, 7706-7710). The phosphoroselenoate was somewhat less active, and was much more toxic to the cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682524      PMCID: PMC334959          DOI: 10.1093/nar/17.20.8207

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

Review 1.  Nucleoside phosphorothioates.

Authors:  F Eckstein
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 2.  Oligonucleotide analogues as potential chemotherapeutic agents.

Authors:  G Zon
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

3.  Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide.

Authors:  C Majumdar; C A Stein; J S Cohen; S Broder; S H Wilson
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

4.  The use of Xenopus oocytes for the expression of cloned genes.

Authors:  J B Gurdon; M P Wickens
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Resolution of hemoglobin subunits by electrophoresis in acid urea polyacrylamide gels containing Triton X-100.

Authors:  G Rovera; C Magarian; T W Borun
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

6.  Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.

Authors:  C Cazenave; C A Stein; N Loreau; N T Thuong; L M Neckers; C Subasinghe; C Hélène; J S Cohen; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

7.  Synthesis of d(GC) and d(CG) octamers containing alternating phosphorothioate linkages: effect of the phosphorothioate group on the B-Z transition.

Authors:  R Cosstick; F Eckstein
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

8.  Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).

Authors:  M Matsukura; G Zon; K Shinozuka; C A Stein; H Mitsuya; J S Cohen; S Broder
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

9.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Reversed-phase high-performance liquid chromatographic separation of diastereomeric phosphorothioate analogues of oligodeoxyribonucleotides and other backbone-modified congeners of DNA.

Authors:  W J Stec; G Zon; B Uznanski
Journal:  J Chromatogr       Date:  1985-06-19
View more
  8 in total

1.  Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides.

Authors:  I Demirhan; O Hasselmayer; D Hofmann; A Chandra; F P Svinarchuk; V V Vlassov; J Engels; P Chandra
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

2.  Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.

Authors:  T Vickers; B F Baker; P D Cook; M Zounes; R W Buckheit; J Germany; D J Ecker
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

3.  Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element.

Authors:  J Laurence; S K Sikder; J Kulkosky; P Miller; P O Ts'o
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  A circular trans-acting hepatitis delta virus ribozyme.

Authors:  M Puttaraju; A T Perrotta; M D Been
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

5.  Use of a novel 5'-regioselective phosphitylating reagent for one-pot synthesis of nucleoside 5'-triphosphates from unprotected nucleosides.

Authors:  Julianne Caton-Williams; Rudiona Hoxhaj; Bilal Fiaz; Zhen Huang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2013-03

Review 6.  The role of the 5' untranslated region of eukaryotic messenger RNAs in translation and its investigation using antisense technologies.

Authors:  K Pantopoulos; H E Johansson; M W Hentze
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

7.  Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2.

Authors:  Ewelina Weglarz-Tomczak; Jakub M Tomczak; Michał Talma; Małgorzata Burda-Grabowska; Mirosław Giurg; Stanley Brul
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

8.  Solid-phase synthesis and structural characterisation of phosphoroselenolate-modified DNA: a backbone analogue which does not impose conformational bias and facilitates SAD X-ray crystallography.

Authors:  Patrick F Conlon; Olga Eguaogie; Jordan J Wilson; Jamie S T Sweet; Julian Steinhoegl; Klaudia Englert; Oliver G A Hancox; Christopher J Law; Sarah A Allman; James H R Tucker; James P Hall; Joseph S Vyle
Journal:  Chem Sci       Date:  2019-10-11       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.